Nanostructured silver (Ag) and gold (Au) are widely known to be potent biocidal and cytotoxic agents as well as biocompatible nanomaterials. It has been recently reported that combining both metals in a specific chemical composition causes a significant enhancement in their antibacterial activity against antibiotic-resistant bacterial strains, as well as in their anticancer effects, while preserving cytocompatibility properties. In this work, Ag/Au bimetallic nanoparticles over a complete atomic chemical composition range were prepared at 10 at% through a green, highly reproducible, and simple approach using starch as a unique reducing and capping agent. The noble metal nanosystems were thoroughly characterized by different analytical techniques, including UV-visible and FT-IR spectroscopies, XRD, TEM/EDS, XPS and ICP-MS. Moreover, absorption spectra simulations for representative colloidal Ag/Au-NP samples were conducted using FDTD modelling. The antibacterial properties of the bimetallic nanoparticles were determined against multidrug-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus, showing a clear dose-dependent inhibition even at the lowest concentration tested (5 µg/mL). Cytocompatibility assays showed a medium range of toxicity at low and intermediate concentrations (5 and 10 µg/mL), while triggering an anticancer behavior, even at the lowest concentration tested, in a process involving reactive oxygen species production per the nanoparticle Au:Ag ratio. In this manner, this study provides promising evidence that the presently fabricated Ag/Au-NPs should be further studied for a wide range of antibacterial and anticancer applications.
The electrophysiological basis of emotion regulation (ER) has gained increased attention since efficient emotion recognition and ER allow humans to develop high emotional intelligence. However, no methodological standardization has been established yet. Therefore, this paper aims to provide a critical systematic review to identify experimental methodologies that evoke emotions and record, analyze and link electrophysiological signals with emotional experience by statistics and artificial intelligence, and lastly, define a clear application of assessing emotion processing. A total of 42 articles were selected after a search based on six scientific browsers: Web of Science, EBSCO, PubMed, Scopus, ProQuest and ScienceDirect during the first semester of 2020. Studies were included if (1) electrophysiological signals recorded on human subjects were correlated with emotional recognition and/or regulation; (2) statistical models, machine or deep learning methods based on electrophysiological signals were used to analyze data. Studies were excluded if they met one or more of the following criteria: (1) emotions were not described in terms of continuous dimensions (valence and arousal) or by discrete variables, (2) a control group or neutral state was not implemented, and (3) results were not obtained from a previous experimental paradigm that aimed to elicit emotions. There was no distinction in the selection whether the participants presented a pathological or non-pathological condition, but the condition of subjects must have been efficiently detailed for the study to be included. The risk of bias was limited by extracting and organizing information on spreadsheets and participating in discussions between the authors. However, the data size selection, such as the sample size, was not considered, leading to bias in the validity of the analysis. This systematic review is presented as a consulting source to accelerate the development of neuroengineering-based systems to regulate the trajectory of emotional experiences early on.
22 September 2021 in Journal of Medical and Biological Engineering